CARRIE McALLISTER, PH.D., earned her B.S. in in Biochemistry and Molecular Biophysics from the University of Arizona in 2005. In the following three years, she studied the neuroprotective effects of testosterone in a male mouse model of Alzheimer’s disease before deciding to pursue her PhD in Neuroscience at the University of Kansas, where she investigated the ability of estradiol to accelerate the therapeutic effects of SSRIs for the treatment of depression. Tired of Kansas winters, she moved to the University of Texas Medical Branch in Galveston in 2014 for her postdoctoral training, where she led a drug discovery effort in the development of novel therapeutics for the treatment of cocaine use disorder. As an entrepreneurial fellow at Fannin, Carrie has been instrumental in determining market fit for device companies. She concentrates in assay development and drug discovery for portfolio companies. In her free time, she enjoys restoring and sailing historic tall ships.
Contact: carrie at fannininnovation dot com